CLSI EP17-A2-2012 临床实验室测量程序检测能力评价.pdf,EP17-A2 Vol. 32 No. 8 Replaces EP17-A Vol. 24 No. 34 Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline—Second Edition This document provides guidanc
CLSI EP17-A2 检出限和定量限的建立与验证.pdf,EP17-A2 Vol. 32 No. 8 Replaces EP17-A Vol. 24 No. 34 Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline—Second Edition This document provides guidance for eva
CLSI EP24-A2-2011 标准名称:评估实验室测试诊断准确性使用受试者操作特征曲线;第二版批准指南 适用范围: 此标准提供了评估测试准确性的协议,用于区分两类具有临床相关性区别的受试者。它强调了定义问题、选择样本组以及确定“真实”临床状态的重要性。除了使用接收器操作特征曲线和比较两条曲线外,该指南还讨论了...
(OPA) according to the guideline (EP12-A2) for the evaluation of qualitative assays published by the Clinical Laboratory Standards Institute (CLSI). Resul... FH Wians,HA Moore,B Donna,... - 《Laboratory Medicine》 被引量: 6发表: 2011年 A-237 Analytical Performance Evaluation of Cytomegalovi...
As EP5 and EP9 evolve into guidelines exclusively for manufacturers, EP15 will become the main guideline for laboratoryusers. Laboratories will use EP15 for verification of manufacturers’ claims for precision and trueness. These changes, or more specific intended uses, accommodate the need for more...
CLSI Documents on File in CQI Office
Martinuzzo MBarrera LHRodriguez MViviana AMartinuzzo, M.,Barrera,etc.Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?[J].2015,37(6)....
EP24-A2 Vol. 31 No. 23 Replaces GP10-A Vol. 15 No. 19 Assessment of the Diagnostic Accuracy of Laboratory Tests Using Receiver Operating Characteristic Curves; Approved Guideline—Second Edition This document provides a protocol for evaluating the accuracy of a test to discriminate between two...
EP15-A2 User Verification of Performance for Precision and Trueness; Approved Guideline – Second Edition (Vol. 25, No. 17) June 2005 EP17-A Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline (Vol. 24, No. 34) October 2004 EP18-A Quality Man...
CLSI MM05-A2-2012 适用范围 分子方法在临床诊断中的应用已成为病理学实践的重要组成部分。在血液病理学中,分子方法用于识别克隆细胞增殖、染色体易位、异常 RNA 种类的产生、肿瘤细胞群的体细胞突变以及异常核酸的定量。随着新检测方法的发展,分子病理学家积极致力于确定分子诊断检测的临床场景并提高分子诊断检测的质量...